Literature DB >> 12688621

The environment and childhood asthma (ECA) study in Oslo: ECA-1 and ECA-2.

Karin C Lødrup Carlsen1.   

Abstract

An observed increase in asthma admissions in Oslo during the 1980s prompted a prospective birth cohort study to ask the following question: was air pollution (outdoor and indoor) (in a broad sense) associated with asthma development in young children? During 12 months from 1 January 1992, 3,754 children (birth weight > or = 2,000 g) in Oslo were enrolled at birth into the Environment and Childhood Asthma (ECA) study and followed to 2 years of age (ECA-part I). Cord blood, a detailed questionnaire (family and pregnancy history of disease, environmental exposures, socio-economic status) completed by the mother and lung function measurements (n = 803) were collated at birth. Detailed questionnaires completed every 6 months for 2 years included the child's disease history, feeding habits and environmental exposures. A nested case-control study comprised 306 children with confirmed minimum two episodes of bronchial obstruction (rBO) and 306 controls (without lower respiratory tract disease) with clinical investigations (including tidal breathing lung function, beta-2 responsiveness and allergy assessment) and environmental exposure assessments (indoor and outdoor). Home dampness and low ventilation, as well as maternal smoking in pregnancy, but not outdoor air pollution increased the risk of rBO. Lung function at birth was decreased among newborns whose mother smoked during pregnancy. To understand better the early risk factors for asthma and allergy development, a follow-up study started (in 2001; ECA-part II) of all cases and controls, and those with lung function measured at birth (total 1,230 invited) (9-10 years of age). This involved clinical investigation, allergy assessments, lung function, airway hyper responsiveness measures, exhaled nitric oxide and immunological as well as allergen exposure investigations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12688621     DOI: 10.1034/j.1399-3038.13.s.15.2.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  10 in total

Review 1.  Eczema in early life: genetics, the skin barrier, and lessons learned from birth cohort studies.

Authors:  Jocelyn M Biagini Myers; Gurjit K Khurana Hershey
Journal:  J Pediatr       Date:  2010-08-24       Impact factor: 4.406

2.  The Paris prospective birth cohort study: which design and who participates?

Authors:  B Clarisse; L Nikasinovic; R Poinsard; J Just; I Momas
Journal:  Eur J Epidemiol       Date:  2007-02-06       Impact factor: 8.082

Review 3.  Asthma: epidemiology, etiology and risk factors.

Authors:  Padmaja Subbarao; Piush J Mandhane; Malcolm R Sears
Journal:  CMAJ       Date:  2009-09-14       Impact factor: 8.262

4.  Pulmonary function and incident bronchitis and asthma in children: a community-based prospective cohort study.

Authors:  Yungling Leo Lee; Bing-Fang Hwang; Yu-An Chen; Jer-Min Chen; Yi-Fan Wu
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

5.  Urinary biomarkers for phthalates associated with asthma in Norwegian children.

Authors:  Randi J Bertelsen; Karin C Lødrup Carlsen; Antonia M Calafat; Jane A Hoppin; Geir Håland; Petter Mowinckel; Kai-Håkon Carlsen; Martinus Løvik
Journal:  Environ Health Perspect       Date:  2012-11-16       Impact factor: 9.031

6.  Intra-individual changes in DNA methylation not mediated by cell-type composition are correlated with aging during childhood.

Authors:  Kristina Gervin; Bettina Kulle Andreassen; Hanne Sagsveen Hjorthaug; Karin C Lødrup Carlsen; Kai-Håkon Carlsen; Dag Erik Undlien; Robert Lyle; Monica Cheng Munthe-Kaas
Journal:  Clin Epigenetics       Date:  2016-10-21       Impact factor: 6.551

7.  Milk Other Than Breast Milk and the Development of Asthma in Children 3 Years of Age. A Birth Cohort Study (2006⁻2011).

Authors:  Asmaa El-Heneidy; Manar E Abdel-Rahman; Gabor Mihala; Lynda J Ross; Tracy A Comans
Journal:  Nutrients       Date:  2018-11-19       Impact factor: 5.717

8.  The use of the MeDALL-chip to assess IgE sensitization: a new diagnostic tool for allergic disease?

Authors:  Ingebjørg Skrindo; Christian Lupinek; Rudolf Valenta; Vegard Hovland; Sandra Pahr; Alexandra Baar; Kai-Håkon Carlsen; Petter Mowinckel; Magnus Wickman; Erik Melen; Jean Bousquet; Josep M Anto; Karin C Lødrup Carlsen
Journal:  Pediatr Allergy Immunol       Date:  2015-05       Impact factor: 6.377

9.  Is the global rise of asthma an early impact of anthropogenic climate change?

Authors:  Paul John Beggs; Hilary Jane Bambrick
Journal:  Environ Health Perspect       Date:  2005-08       Impact factor: 9.031

Review 10.  Paving the way of systems biology and precision medicine in allergic diseases: the MeDALL success story: Mechanisms of the Development of ALLergy; EU FP7-CP-IP; Project No: 261357; 2010-2015.

Authors:  J Bousquet; J M Anto; M Akdis; C Auffray; T Keil; I Momas; D S Postma; R Valenta; M Wickman; A Cambon-Thomsen; T Haahtela; B N Lambrecht; K C Lodrup Carlsen; G H Koppelman; J Sunyer; T Zuberbier; I Annesi-Maesano; A Arno; C Bindslev-Jensen; G De Carlo; F Forastiere; J Heinrich; M L Kowalski; D Maier; E Melén; S Palkonen; H A Smit; M Standl; J Wright; A Asarnoj; M Benet; N Ballardini; J Garcia-Aymerich; U Gehring; S Guerra; C Hohman; I Kull; C Lupinek; M Pinart; I Skrindo; M Westman; D Smagghe; C Akdis; R Albang; V Anastasova; N Anderson; C Bachert; S Ballereau; F Ballester; X Basagana; A Bedbrook; A Bergstrom; A von Berg; B Brunekreef; E Burte; K H Carlsen; L Chatzi; J M Coquet; M Curin; P Demoly; E Eller; M P Fantini; B Gerhard; H Hammad; L von Hertzen; V Hovland; B Jacquemin; J Just; T Keller; M Kerkhof; R Kiss; M Kogevinas; S Koletzko; S Lau; I Lehmann; N Lemonnier; R McEachan; M Mäkelä; J Mestres; E Minina; P Mowinckel; R Nadif; M Nawijn; S Oddie; J Pellet; I Pin; D Porta; F Rancière; A Rial-Sebbag; Y Saeys; M J Schuijs; V Siroux; C G Tischer; M Torrent; R Varraso; J De Vocht; K Wenger; S Wieser; C Xu
Journal:  Allergy       Date:  2016-08-23       Impact factor: 13.146

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.